Extended Diagnostics in Cholinergic Urticaria

Recruiting

• Conditions: L50.5; Cholinergic urticaria

• Registration Number: DRKS00012755
• Lead Sponsor: Charité Campus Charité Mitte

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2017-08-02
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 150

Inclusion Criteria

patients with cholinergic urticaria or healthy controls, older than 18 years old, no other dominant skin disease, no other severe systemic disease

Exclusion Criteria

persons below 18 years, severy systemic disease, other dominant skin disease except cholinergic urticaria

Study & Design

• Study Type: observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Blood and skin samples will be taken and analyzed for singal molecules (e.g. Immunoglobulines, Cytokines, (Cytokin-)receptors, etc.) in comparison: patients v.s. healthy controls.

Secondary Outcome Measures

Name	Time	Method
Korrelation of clinical parameter like age, sex, duration of disease, etc. with the determined laboratory markers of the skin- and bloodsamples.